🔗 Share this article

An underground economy for unlicensed slimming drugs is propelled by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Experimental Drug Acquiring Popularity Via Social Media

The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning properties. Viewers are urged to message these profiles privately for source information, while also obtaining promotional offers.

Active Trade on Messaging Platforms

Separately, a robust trade exists on messaging services, where groups with thousands of members share comparison images, administration instructions and claims of next-day UK delivery. Sellers promote the substance there before directing buyers to WhatsApp for purchases.

Learning About Retatrutide

Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could help patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.

Medical Professionals Express Worries

However, doctors and chemists have cautions that the distribution of what is still an unlicensed drug in the United Kingdom is worrisome and could lead to users administering substances of unknown origin.

Some professionals said the demand for the experimental drug could be linked to the increasing cost of licensed slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still violate medicines, marketing, and consumer regulations, potentially leading to fines, prosecution or imprisonment.

Service Reaction and Material Elimination

According to TikTok, the service has removed problematic material and prohibited associated hashtags and search suggestions. The company said it was committed to keeping the service secure and allocating resources in strengthening enforcement strategies.

Online Trading Activities

Research also discovered communities with up to nine thousand members marketing the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Typing “retatrutide” immediately displays groups with numerous of members, populated with photos of slimming results, glowing reviews and detailed instructions for mixing or administering at residence.

After minutes of entering one community, a seller shared contact information, where the majority of purchases take place. The vendor provided an guidebook and promised shipping within 48 hours. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a image of a alleged testing documentation. None asked about weight, medical conditions or previous experience.

Item Information and Costs

Inside these groups, posts display dark colored packages with postal service labels, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with sterile water, or ready-to-use pens typically priced at £160 for 20 milligrams. When asked how long a pen should last, vendors give conflicting answers varying between a several days to “depends on your body”.

Service Oversight and Security Actions

A representative for the messaging service stated it regularly moderated harmful content on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are injecting materials they cannot confirm. Although the research behind retatrutide is sound, these online versions may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current cost increases for authorized slimming medications such as Mounjaro. “With costs increasing, individuals are turning to social media. But fake treatments are extremely dangerous. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she said.

Her staff has previously encountered patients injured by self-injection from unconfirmed suppliers. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your well-being,” stated Wyllie. “These substances could be impure or improperly measured.”

Producer Position

A representative from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or approved by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they said, adding that any product “falsely representing itself as a Lilly experimental product not yet approved … may subject users to potentially significant medical dangers”.